Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acacia Pharma
Acacia Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Barhemsys
Amisulpride
2020-02-26
2031-2038
—
Byfavo
Remimazolam
2020-10-06
2027-2033
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amisulpride
major depressive disorder
,
healthy volunteers/patients
,
gastrointestinal microbiome
,
anorexia
,
anorexia nervosa
,
psychological stress
,
obsessive-compulsive disorder
,
compulsive behavior
,
compulsive personality disorder
,
chronic kidney failure
,
therapeutic equivalency
,
bipolar disorder
,
intellectual disability
,
postoperative nausea and vomiting
,
vomiting
,
nausea
,
dementia
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
sialorrhea
,
schizophrenia
,
psychotic disorders
,
depression
,
mental disorders
,
treatment-resistant schizophrenia
,
depressive disorder
,
schizophrenia spectrum and other psychotic disorders
,
alzheimer disease
,
tardive dyskinesia
,
dyskinesias
,
prodromal symptoms
,
metabolic syndrome
,
hyperprolactinemia
,
syndrome
,
chronic pain
,
myofascial pain syndromes
,
fibromyalgia
,
addictive behavior
,
treatment-resistant depressive disorder
,
diabetes mellitus
,
insulin resistance
,
microvascular angina
,
periodontal diseases
Calcium dobesilate
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
Lornoxicam
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
Bos taurus adrenal cortex corticosteroids
myelodysplastic syndromes
,
myeloid leukemia acute
,
recurrence
,
precursor cell lymphoblastic leukemia-lymphoma
,
neoplasm metastasis
,
biphenotypic leukemia acute
,
polymyalgia rheumatica
,
t-cell lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
ovarian neoplasms
,
atopic dermatitis
,
ulcerative colitis
,
covid-19
,
arteritis
,
takayasu arteritis
,
aortic arch syndromes
,
giant cell arteritis
,
crohn disease
,
eczema
,
dermatitis
,
panuveitis
,
colitis
,
ulcer
Anthracycline
neoplasms
,
hodgkin disease
,
myeloid leukemia acute
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
neutropenia
,
chemotherapy-induced febrile neutropenia
,
non-hodgkin lymphoma
,
lymphoma
,
mantle-cell lymphoma
,
promyelocytic leukemia acute
APD209
wasting syndrome
,
cachexia
Trinessa
healthy volunteers/patients
,
diabetes mellitus
,
pharmacokinetics
,
major depressive disorder
,
neoplasms
,
long qt syndrome
,
alzheimer disease
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
respiration disorders
,
emphysema
,
bronchiolitis
,
rheumatoid arthritis
,
non-alcoholic fatty liver disease
,
alcoholic fatty liver
,
sepsis
,
septic shock
Fluoroquinolone
healthy volunteers/patients
Isoxaflutole
therapeutic equivalency
,
healthy volunteers/patients
,
heart failure
,
cardiovascular diseases
,
heart diseases
,
cardiac arrhythmias
,
laparoscopy
,
growth
,
obesity
,
diet therapy
,
acute lung injury
,
lung injury
,
type 2 diabetes mellitus
,
body weight changes
,
atrial fibrillation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use